Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
This is an open-label multicenter, phase 1-2 study. Following determination of the recommended AEG35156 dose in combination with carboplatin and paclitaxel in the initial Phase 1 part of this study, additional patients will be enrolled in the Phase 2 part of the study to assess the activity of the combination in advanced non small cell lung cancer.
Inclusion criteria
- Carcinoma, Non-Small-Cell Lung